CBLL

CeriBell, Inc.

• PUBT·3d ago

  Ceribell CEO Jane Chao presents at William Blair Growth Stock Conference

• TipRanks·6d ago

  Bank of America Securities Remains a Buy on Ceribell, Inc. (CBLL)

• TipRanks·05/13 09:16

  Ladenburg Thalmann & Co. Remains a Buy on Ceribell, Inc. (CBLL)

• TipRanks·05/13 06:00

  Middle East Tensions Threaten Ceribell’s Supply Chain, Shipping Routes, and Margins

• Simply Wall St·05/12 23:22

  CeriBell (CBLL) Q1 Loss Widens Challenging Bullish Growth Narratives

• Dow Jones·05/12 19:31

  CeriBell Is Maintained at Buy by Canaccord Genuity

• Dow Jones·05/12 19:31

  CeriBell Price Target Cut to $25.00/Share From $28.00 by Canaccord Genuity

• Benzinga·05/12 19:22

  Canaccord Genuity Maintains Buy on CeriBell, Lowers Price Target to $25

• Seeking Alpha·05/12 13:12

  Ceribell anticipates $112M-$116M 2026 revenue while targeting delirium NTAP of up to $2,171 per patient

• TipRanks·05/12 11:28

  Ceribell price target lowered to $25 from $28 at Canaccord

• TipRanks·05/12 10:16

  Brandon Vazquez Reiterates Buy on Ceribell as Strong Commercial Execution and Rapid Pipeline Progress Support Attractive Long-Term Upside

• TipRanks·05/12 09:56

  Ceribell: Buy Rating Reiterated on Strong Q1 Momentum and Expanded TAM, $28 Price Target Maintained

• TipRanks·05/12 01:30

  Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL) and AbCellera Biologics (ABCL)

• TipRanks·05/12 00:56

  Ceribell’s Earnings Call Signals Growth Over Profits

• TipRanks·05/11 21:24

  Ceribell reports Q1 EPS (52c), consensus (39c)